- Q1 2024 Chimerix Inc Earnings Call TranscriptMay 01, 2024Earnings
- Q4 2023 Chimerix Inc Earnings Call TranscriptFeb 29, 2024€1.12 (-7.95%)Earnings
- Q3 2023 Chimerix Inc Earnings Call TranscriptNov 02, 2023€0.8992 (+2.51%)Earnings
- Q2 2023 Chimerix Inc Earnings Call TranscriptAug 03, 2023€1.04Earnings
- Chimerix Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 Chimerix Inc Earnings Call TranscriptMay 04, 2023€1.02 (-0.44%)Earnings
- Q4 2022 Chimerix Inc Earnings Call TranscriptMar 02, 2023€1.55 (+6.01%)Earnings
- Chimerix Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Q3 2022 Chimerix Inc Earnings Call TranscriptNov 03, 2022€1.82 (-4.55%)Earnings
- Q2 2022 Chimerix Inc Earnings Call TranscriptAug 08, 2022€2.26 (-10.79%)Earnings
- Q1 2022 Chimerix Inc Earnings Call TranscriptMay 16, 2022€2.04 (-41.86%)Earnings
- Q4 2021 Chimerix Inc Earnings Call TranscriptMar 01, 2022€4.87 (-1.78%)Earnings
- Chimerix Inc to Discuss Positive ONC201 Data in Recurrent H3 K27M-mutant Diffuse Midline Glioma Call TranscriptNov 22, 2021
- Chimerix Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 08, 2021
- Q3 2021 Chimerix Inc Earnings Call TranscriptNov 04, 2021€5.21 (+4.73%)Earnings
- Q2 2021 Chimerix Inc Earnings Call TranscriptAug 05, 2021€5.57 (+4.90%)Earnings
- Chimerix Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- Q1 2021 Chimerix Inc Earnings Call TranscriptMay 06, 2021€6.6 (-11.06%)Earnings
- Q4 2020 Chimerix Inc Earnings Call TranscriptFeb 25, 2021€8.48 (+3.41%)Earnings
- Chimerix Inc to Acquire Oncoceutics Inc - Conference Call TranscriptJan 08, 2021
- Chimerix Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 12, 2020
- Q3 2020 Chimerix Inc Earnings Call TranscriptNov 05, 2020€2.5 (+0.81%)Earnings
- Q2 2020 Chimerix Inc Earnings Call TranscriptAug 10, 2020€2.68Earnings
- Chimerix Inc DSTAT Clinical Update Conference Call TranscriptApr 29, 2020
- Q4 2019 Chimerix Inc Earnings Call TranscriptFeb 25, 2020€1.71 (+11.76%)Earnings
- Chimerix Inc at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 13, 2019
- Q3 2019 Chimerix Inc Earnings Call and Operational Updates TranscriptNov 05, 2019€1.39 (-2.11%)Earnings
- Chimerix Inc CX-01 Call TranscriptJul 31, 2019
- Q1 2019 Chimerix Inc Earnings Call TranscriptMay 09, 2019€2.5 (+6.38%)Earnings
- Q4 2018 Chimerix Inc Earnings Call TranscriptMar 05, 2019€1.8 (-8.16%)Earnings
Chimerix Inc to Acquire Oncoceutics Inc - Conference Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Chimerix Oncoceutics acquisition conference call.
(Operator Instructions)
I would now like to hand the conference to your speaker today, Mike Sherman. Please go ahead, sir.
Good morning, everyone, and thanks for joining us. Really pleased to be able to share with you our excitement about the acquisition of Oncoceutics and their pipeline of precision small molecule oncology assets. With me on the call today is Mike Andriole, Chief Financial and Business Officer; Allen Melemed, our Chief Medical Officer; Randall Lanier, our Chief Scientific Officer; and Josh Allen, Scientific Officer -- Chief Scientific Officer of Oncoceutics.
My comments today will follow a presentation that we posted on the Presentations page of the Investor Relations section of our website, so please feel free to follow along. The (inaudible) teams executed extremely well in advancing brincidofovir this year, now well into the NDA
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)